HSS Signs Agreement with Hospital Alvorada in Brazil

Orthopedics This Week—May 2, 2014

Hospital for Special Surgery (HSS) in New York is announcing that it has signed a four-year agreement to provide a wide range of consulting services to Hospital Alvorada (São Paulo, Brazil), focusing on its Department of Orthopedic Surgery. The partnership with Alvorada is the second collaboration with a Brazilian hospital. In 2013, HSS signed a multi-year agreement with Amil, Brazil's largest managed healthcare organization, to provide services in quality management, clinical pathways and academic training at its newly opened orthopedic specialty hospital, Hospitalys Ortopedia, in Rio de Janeiro.

Hospital Alvorada is also part of the Amil network. The partnership between HSS and Hospital Alvorada will focus on clinical pathways and quality initiatives to grow its orthopedic surgery department and establish its reputation as a leader in the field. The Alvorada collaboration will have an emphasis on total joint replacement. Educational programs will be available year-round to Hospital Alvorada staff via access to HSS eAcademy, which offers a variety of symposia, seminars, videos and continuing medical education courses online. Special offerings will also be developed for physicians, physical therapists and nurses affiliated with the hospitals owned by Amil.

Asked what made this particular hospital (Hospital Alvorada) a great choice for HSS, Louis A. Shapiro, president and CEO of Hospital for Special Surgery, told OTW, "First of all, there is our 2013 agreement with Amil. Hospital Alvorada, part of the Amil network, is an established general hospital interested in growing its orthopedic surgery department and establishing its reputation as a leader in the field in Sao Paulo, Brazil. One of the areas we will focus on with Hospital Alvorada is total joint replacement, where we have a great deal of experience. We perform almost 10,000 joint replacements annually at Hospital for Special Surgery. We are very interested in continuing to expand our partnership with Amil, as we have parallel missions and values, and we have a strong commitment to advance the field of musculoskeletal medicine."